[1]
E. Shafique, “Efficacy and Safety of insulin degludec/aspart (RyzoDeg) in Type 2 Diabetes Mellitus in Pakistan: Real-Life Experience”, J Pak Endo Society, vol. 1, no. 2, pp. 53–57, Jan. 2025.